价值工程
價值工程
개치공정
VALUE ENGINEERING
2014年
16期
174-175
,共2页
医药企业%核心竞争力%指标构建%综合模糊评价
醫藥企業%覈心競爭力%指標構建%綜閤模糊評價
의약기업%핵심경쟁력%지표구건%종합모호평개
pharmaceutical companies%core competitiveness%index construction%comprehensive fuzzy evaluation
本文从分析我国医药企业存在的问题以及对影响医药企业核心竞争力形成的制约因素出发,并结合医药企业自身特点,按照定性和定量相结合的原则,设置了医药企业核心竞争力的指标体系,建立综合模糊评价模型。
本文從分析我國醫藥企業存在的問題以及對影響醫藥企業覈心競爭力形成的製約因素齣髮,併結閤醫藥企業自身特點,按照定性和定量相結閤的原則,設置瞭醫藥企業覈心競爭力的指標體繫,建立綜閤模糊評價模型。
본문종분석아국의약기업존재적문제이급대영향의약기업핵심경쟁력형성적제약인소출발,병결합의약기업자신특점,안조정성화정량상결합적원칙,설치료의약기업핵심경쟁력적지표체계,건립종합모호평개모형。
This paper analyzes the problems of pharmaceutical enterprises in China and the factors affecting the formation of pharmaceutical enterprise's core competence, and combined with the characteristics of pharmaceutical enterprise, according to the principle of combining qualitative and quantitative, a pharmaceutical enterprise core competitiveness index system is set, and the comprehensive fuzzy evaluation model is set up.